<DOC>
	<DOC>NCT00381537</DOC>
	<brief_summary>Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.</brief_summary>
	<brief_title>Prediction of Childhood Epilepsy Outcome in Bangladesh</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Phenobarbital</mesh_term>
	<criteria>Active epilepsy Aged 215 years Excluded absence Myoclonic and malignant epilepsy syndromes Major motor and cognitive impairments Those currently receiving antiepilepsy drugs.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>childhood epilepsy</keyword>
	<keyword>Active childhood epilepsy</keyword>
</DOC>